# Shaq's Sleep Apnea Improvement Highlights Weight Loss Drug's Other Benefits
Shaquille O'Neal recently shared that Zepbound helped him manage sleep apnea alongside weight loss. The NBA legend's experience points to a growing body of evidence showing GLP-1 receptor agonists like Zepbound (semaglutide) work beyond dropping pounds.
Sleep apnea occurs when throat muscles relax during sleep, blocking airways. Excess weight worsens the condition by narrowing airways further. When patients lose weight through medications like Zepbound, their sleep apnea often improves dramatically.
Research published in medical journals confirms this connection. A study in Chest Journal found that patients using GLP-1 agonists experienced reduced sleep apnea severity along with weight loss. The improvement happens because less body weight means less pressure on airways, allowing easier breathing during sleep.
For parents, this matters if a family member struggles with both obesity and sleep apnea. Zepbound requires a prescription and weekly injections. Side effects include nausea, vomiting, and diarrhea, typically mild and temporary.
Sleep apnea itself poses real health risks. The condition interrupts oxygen flow to the brain and heart. Untreated sleep apnea increases stroke and heart attack risk. Children and adults both can develop it, though adult obesity-related cases are more common.
O'Neal's public disclosure normalizes conversations about weight management medications. His willingness to discuss using Zepbound removes shame often surrounding these drugs. Many people benefit from pharmaceutical support alongside lifestyle changes like diet and exercise.
If your family member shows signs of sleep apnea (loud snoring, gasping during sleep, daytime exhaustion), talk to their doctor first. A sleep study can confirm diagnosis. Your doctor can discuss whether Z